← Evidence map

ArticleJournal of postgraduate medicine

Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?

Ranjan GuptaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 32134006